NOV 10, 2020 8:45 AM PST

Liposomal Delivery Could Help Prevent Doxorubicin Cardiotoxicity

WRITTEN BY: Jasper Cantrell

One of the greatest failures of modern cancer therapies is the rather substantial off-target toxic effects many radio-, chemo-, and immunotherapies have. We have made great strides to improve these treatments but never-the-less struggle to get toxicity-free therapy to patients.

Cancer therapies range in methodology, mechanism of action, and effectiveness. Some therapies favor certain types of cancers, while others seem to affect a variety of cancers. Unfortunately, nearly all of these therapies essentially involve poisons that are designed to target cancer cells. As cancer cells are nearly identical to healthy cells in most ways, this often leads to off-target toxicities. These toxicities need to be accounted for before a patient engages in any specific treatment.

Breast cancer is one of the most common cancers in the world, with many well-studied treatments. One such treatment is doxorubicin, which unfortunately has some issues with cardiotoxicity. However, a newer version of doxorubicin using liposomal delivery (a type of delivery system using lipids) has shown to be less cardiotoxic than doxorubicin alone.

In a new study, a team from the Centre of Postgraduate Medical Education in Poland investigated how liposomal doxorubicin affected patient factors like overall survival and the amount of cardiotoxicity experienced. They did this by taking data from eight oncology centers in Poland and analyzing liposomal doxorubicin therapy results against other cancer therapies.

The team gathered data from 402 metastatic breast cancer patients, of which only 126 managed to complete their liposomal doxorubicin treatments. Analyzing these patients’ heart health and comparing them to patients treated with doxorubicin alone or other similar chemotherapies showed that liposomal doxorubicin was linked to a healthier heart after treatment. Overall survival comparison showed that only when liposomal doxorubicin was a secondary therapy or other specific incidences was there a significant difference.

With toxicity being a consistent issue with many cancer therapies, there is a keen interest in producing a therapy with little to no toxic side-effects. Liposomal doxorubicin is one such option, and this study found that it had lower cardiotoxicity than doxorubicin alone. This finding supports the use of liposomal doxorubicin in patients at a high risk of cardiovascular disease.

The team concludes that there needs to be more study, as several other factors increase cardiovascular disease incidence, such as diabetes.  The study concludes, “in patients with metastatic BC, prolonged liposomal doxorubicin treatment, i.e. lasting more than 3.5 months, and thus the administration of a higher cumulative dose, i.e. above 300 mg/m2, significantly increases OS.”

Sources: Nature Scientific Reports, British Heart Foundation

About the Author
Bachelors of the Sciences
Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
FEB 16, 2022
Genetics & Genomics
Protective Genetic Variants Can Shield Carriers From Disease
FEB 16, 2022
Protective Genetic Variants Can Shield Carriers From Disease
The human genome contains mostly the same genes from one person to another, but there are tiny sequence differences in t ...
FEB 19, 2022
Health & Medicine
The Search for Genetic Links in Sudden Unexplained Child Deaths
FEB 19, 2022
The Search for Genetic Links in Sudden Unexplained Child Deaths
Sudden unexplained death in childhood (SUDC), similar to sudden infant death syndrome (SIDS), occurs when children betwe ...
MAR 31, 2022
Cancer
New Study Finds No Link between Childhood Obesity and Thyroid Cancer
MAR 31, 2022
New Study Finds No Link between Childhood Obesity and Thyroid Cancer
The incidence of thyroid cancer among children has been increasing over recent decades. Similarly, cases of childhood ob ...
APR 24, 2022
Technology
Portable MRIs for Detecting Stroke
APR 24, 2022
Portable MRIs for Detecting Stroke
Strokes are considered medical emergencies. They happen quickly and with devastating results. During a stroke, blood flo ...
MAY 12, 2022
Clinical & Molecular DX
Researchers Show Influenza Directly Infects the Heart
MAY 12, 2022
Researchers Show Influenza Directly Infects the Heart
Heart complications are often observed in severe or fatal cases of Influenza. These problems can include electrical malf ...
JUN 25, 2022
Health & Medicine
Excess Sitting Is Bad for Your Health but Exercise Can Help with That
JUN 25, 2022
Excess Sitting Is Bad for Your Health but Exercise Can Help with That
Winston Churchill said, "Never stand up when you can sit down." Nowadays, sitting down is an unavoidable part ...
Loading Comments...